OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations
Elena Manara, Valéria Bisio, Riccardo Masetti, et al.
Leukemia (2013) Vol. 28, Iss. 5, pp. 1132-1134
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Detection of KIT mutations in core binding factor acute myeloid leukemia
Passant Badr, Ghada M. El‐Sayed, Dalia Negm Eldin, et al.
Leukemia Research Reports (2018) Vol. 10, pp. 20-25
Open Access | Times Cited: 17

Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia
Claudia Tregnago, Maddalena Benetton, Ambra Da Ros, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 9

The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes
Linda Olsson, Sofia Zettermark, Andrea Biloglav, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 292-301
Open Access | Times Cited: 12

Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia
Jae Wook Lee, Seongkoo Kim, Pil‐Sang Jang, et al.
Journal of Pediatric Hematology/Oncology (2019) Vol. 42, Iss. 3, pp. e132-e139
Closed Access | Times Cited: 11

Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study
Jiapeng Yang, Xiaohua Zhu, Honghong Zhang, et al.
Children (2024) Vol. 11, Iss. 5, pp. 605-605
Open Access | Times Cited: 1

Influence of KIT mutations on prognosis of pediatric patients with core-binding factor acute myeloid leukemia: a systematic review and meta-analysis
Junjie Fan, Li Gao, Jing Chen, et al.
Translational Pediatrics (2020) Vol. 9, Iss. 6, pp. 726-733
Open Access | Times Cited: 10

A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1 -RUNX1T1 acute myeloid leukaemia
Matteo Zampini, Valéria Bisio, Anna Leszl, et al.
British Journal of Haematology (2017) Vol. 183, Iss. 2, pp. 298-301
Open Access | Times Cited: 9

Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients
Fan Zhou, Fen Zhou, Mengyi Du, et al.
International Journal of Hematology (2019) Vol. 110, Iss. 5, pp. 575-583
Closed Access | Times Cited: 9

Co-occurrence of KIT and NRAS mutations defines an adverse prognostic core-binding factor acute myeloid leukemia
Huimin Jin, Yu Zhu, Ming Hong, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 10, pp. 2428-2437
Closed Access | Times Cited: 8

Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute Leukemia
Clara Vicente‐Garcés, Elena Esperanza‐Cebollada, Sara Montesdeoca, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6

KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1
Shyam Srinivasan, Chetan Dhamne, Nikhil Patkar, et al.
Pediatric Blood & Cancer (2023) Vol. 71, Iss. 2
Open Access | Times Cited: 3

Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia
Fan Yang, Li Zhang, Beibei Zhao, et al.
Clinical Pharmacokinetics (2021) Vol. 61, Iss. 1, pp. 71-81
Closed Access | Times Cited: 6

Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia
Hironori Arai, Yosuke Minami, SungGi Chi, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3008-3008
Open Access | Times Cited: 3

Cytogenetics of Acute Leukemia
Nyla A. Heerema, Susana C. Raimondi
Springer eBooks (2017), pp. 281-306
Closed Access | Times Cited: 3

Clinical significance of droplet digital PCR quantitative monitoring of KIT gene mutation levels in core binding factor leukemia
Zhuang Liu, Wenjun Wang, Chaofeng Zheng, et al.
International Journal of Laboratory Hematology (2018) Vol. 40, Iss. 6
Closed Access | Times Cited: 3

Targeted drugs in the treatment of acute myeloid leukemia in children
G. Z. Seregin, A. V. Lifshits, Т. Т. Валиев
Russian Journal of Pediatric Hematology and Oncology (2020) Vol. 7, Iss. 3, pp. 78-85
Open Access | Times Cited: 2

Diagnosis and Treatment of Pediatric Acute Myeloid Leukemia
Jae Wook Lee, Bin Cho
Imsang soa hyeoraek jong-yang/Imsang soa hyeol'aeg jong'yang/Clinical pediatric hematology-oncology (2015) Vol. 22, Iss. 1, pp. 8-14
Open Access | Times Cited: 1

Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia
Zhuojun Zheng, Xiao-Dong Li, Yuandong Zhu, et al.
Oncotarget (2016) Vol. 7, Iss. 44, pp. 71526-71535
Open Access | Times Cited: 1

Previous Page - Page 2

Scroll to top